Last updated on April 24, 2014 at 1:21 EDT

A 300 Million Euro Boost for Biomedicine in Berlin

November 13, 2012

BERLIN, November 13, 2012 /PRNewswire/ –

Two of Berlin’s largest biomedical research centers are merging to form the Berlin
Institute of Health (BHI), a joint venture that will receive at least 300 million euros in
new funding over the next five years. This makes Berlin an even more significant and
attractive research site, not only in the field of biomedicine. This is happening at the
right time, for an aging demographic means that there is an increasing demand for health
care products and services. Germany Trade & Invest will have experts at this year’s
MEDICA, the world’s largest health fair, from November 14 to 17 to inform visitors about
the industry’s latest business opportunities.

“The BHI will make Berlin one of the world’s top sites for medical excellence and will
attract the world’s best scientists and junior doctors. The partnership between the Berlin
state and federal government has created an exemplary model of cooperation between
university and non-university research. Germany has a globally recognized biomedical
sector, and it will only improve due to the Institute’s innovative models to train medical
talent,” said Dr. Sandra Buetow, chemical and health expert at Germany Trade & Invest.

Germany is renowned for its effective public-private partnerships such as the Central
Innovation Program SME, a country-wide support measure that provides sustainable support
to the innovative capabilities and competiveness of small- and medium-sized enterprises.
Participants include businesses and researchers from the health and wellness industry who
collaborate in order to find innovative and value-added healthcare solutions.

General Electric has also seized on the market opportunity in Germany due to its
infrastructure, research and development and changing demographic. Their objective is to
powerfully expand its medical division and establish close partnerships with university

Germany Trade & Invest is the foreign trade and inward investment agency of the
Federal Republic of Germany. The organization advises foreign companies seeking to expand
into the German market. It supports German companies that seek to enter foreign markets,
with foreign trade information.

        Germany Trade & Invest
        Andreas Bilfinger
        e-mail: andreas.bilfinger@gtai.com
        T: +49(0)30-200099-173




SOURCE Germany Trade and Invest

Source: PR Newswire